Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 7;20(1):96.
doi: 10.1186/s12873-020-00389-w.

Lung ultrasound in the emergency department - a valuable tool in the management of patients presenting with respiratory symptoms during the SARS-CoV-2 pandemic

Bonaventura Schmid  1 , Doreen Feuerstein  2 , Corinna N Lang  3   4 , Katrin Fink  2 , Rebecca Steger  2 , Marina Rieder  3 , Daniel Duerschmied  3   4 , Hans-Jörg Busch  2 , Domagoj Damjanovic  5
Affiliations

Lung ultrasound in the emergency department - a valuable tool in the management of patients presenting with respiratory symptoms during the SARS-CoV-2 pandemic

Bonaventura Schmid et al. BMC Emerg Med. .

Abstract

Background: Typical lung ultrasound (LUS) findings in patients with a COVID-19 infection were reported early on. During the global SARS-CoV-2 pandemic, LUS was propagated as a useful instrument in triage and monitoring. We evaluated LUS as a rapid diagnostic triage tool for the management of patients with suspected COVID-19 in the emergency department (ED).

Methods: The study retrospectively enrolled patients with suspected COVID-19, who were admitted from 1st April to 25th of April 2020 to the ED of a tertiary care center in Germany. During clinical work-up, patients underwent LUS and polymerase chain reaction (PCR) testing for SARS-CoV-2. The recorded ultrasound findings were analyzed and judged regarding typical signs of viral pneumonia, blinded for clinical information of the patients. The results were compared with PCR test and chest computed tomography (CT).

Results: 2236 patients were treated in the ED during the study period. 203 were tested for SARS-CoV-2 using PCR, 135 (66.5%) underwent LUS and 39 (28.9%) of the patients were examined by chest CT scan. 39 (28.9%) of the 135 patients were tested positive for SARS-CoV-2 with PCR. In 52 (38.5%) COVID-19 was suspected from the finding of the LUS, resulting in a sensitivity of 76.9% and a specificity of 77.1% compared with PCR results. The negative predictive value reached 89.2%. The findings of the LUS had - compared to a positive chest CT scan for COVID-19 - a sensitivity of 70.6% and a specificity of 72.7%.

Conclusions: LUS is a rapid and useful triage tool in the work-up of patients with suspected COVID-19 infection during a pandemic scenario. Still, the results of the LUS depend on the physician's experience and skills.

Keywords: COVID-19; Emergency department; Lung ultrasound; Triage.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Patients in the ED during the study period in absolute numbers, percentage refer to the number above. Every suspected case of a SARS-CoV-2 infection was tested using PCR
See this image and copyright information in PMC

References

    1. Mojoli F, Bouhemad B, Mongodi S, Lichtenstein D. Lung ultrasound for critically ill patients. Am J Respir Crit Care Med. 2019;199:701–714. doi: 10.1164/rccm.201802-0236CI. - DOI - PubMed
    1. Vignon P, Repessé X, Vieillard-Baron A, Maury E. Critical care ultrasonography in acute respiratory failure. Crit Care. 2016;20:228. doi: 10.1186/s13054-016-1400-8. - DOI - PMC - PubMed
    1. Kluge S, et al. German recommendations for critically ill patients with COVID-19. Med Klin Intensivmed Notfmed. 2020;2:30079–30074. - PMC - PubMed
    1. Smith MJ, Hayward SA, Innes SM, Miller ASC. Point-of-care lung ultrasound in patients with COVID-19 - a narrative review. Anaesthesia. 2020;24:2776. - PMC - PubMed
    1. Wan D-Y, Luo X-Y, Dong W, Zhang Z-W. Current practice and potential strategy in diagnosing COVID-19. Eur Rev Med Pharmacol Sci. 2020;24:4548–4553. - PubMed

Publication types